Has Sriharan Sivalingam, MD received payments from drug or device companies?

Yes. Drug and device makers reported $275,839 in general payments to Sriharan Sivalingam, MD across 319 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sriharan Sivalingam, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sriharan Sivalingam, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sriharan Sivalingam, MD

Urology · Cleveland, OHNPI 1740553015

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by C. R. Bard, Inc. & Subsidiaries at 42.9% of the total. 2025 is the largest year on record at $76,897, 3.4 times the $22,828 reported in 2019. Among urology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$275,839in general payments, 2019–2025

Across 319 payments — averaging $864.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

C. R. Bard, Inc. & Subsidiaries$118K
KARL Storz Endoscopy-america$52K
Cook Incorporated$31K
Olympus America Inc.$16K
BK Medical Holding Company Inc.$12K
Johnson & Johnson$10K
plus $37K from 18 others

$6,034in research payments, 2019–2025

Across 3 payments — averaging $2011.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

KARL Storz Endoscopy-america$6K

What the payments were for

Consulting fees$110,46140%
Speaking & faculty fees$131,59548%
Travel & lodging$20,0687%
Food & beverage$13,6495%
Education$660%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
C. R. Bard, Inc. & Subsidiaries	77	$118,289
KARL Storz Endoscopy-america	42	$51,831
Cook Incorporated	13	$30,753
Olympus America Inc.	19	$16,493
BK Medical Holding Company Inc.	4	$11,564
Johnson & Johnson(2 entities)	14	$10,228
Boston Scientific	32	$9,802
Ambu Inc.	14	$9,360
Richard Wolf Medical Instruments Corp.	9	$5,664
Cook Medical LLC	44	$4,572
Calyxo, Inc.	17	$3,741
Gyrus ACMI, Inc.	2	$1,080
Intuitive Surgical	1	$700
Urogen Pharma, Inc.	3	$463
Coloplast	4	$445
Davol Inc.	4	$258
Procept Biorobotics Corporation	2	$232
Rochester Medical Corporation	5	$165
Astellas Pharma US Inc	4	$66
BD	2	$41
Endo Pharmaceuticals Inc.	3	$38
AbbVie	2	$27
Metuchen Pharmaceuticals	1	$17
Pfizer	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Flex-X$36,792
Soltive$16,116
S~Curve$14,635
bk3000, bk3500 & bk5000 Ultrasound System$11,564
Monarch Platform$9,974
Flex-X / IMAGE 1 S$9,250
Cook Medical Urology$6,641
GENERAL KIDNEY STONE DISEASE$6,501
Cook Medical Dilation/Access$5,457
LITHO 150$4,712
NEPHROSCOPE MIP M$4,112
CVAC Aspiration System$3,446
Cook$1,935
Bard Urinary Drainage Bag$1,337
GENERAL - THERAPIES$981
Da Vinci Surgical System$700
LithoVue$539
JELMYTO$463
Cook Medical NCircle$458
LITHOCLAST$262

How this compares

$275,839 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.

See all urology providers in Ohio →

Medicare billing

Part B allowed, 2024

$100,898

Medicare patients

191

Services billed

486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	34	$399
Tamsulosin Hcl	43	$167
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	14	$51

Paid to pharmacies, not to this prescriber.

Other urology in Cleveland

Howard GoldmanCleveland$721K
Sandip VasavadaCleveland$263K
Jihad KaoukCleveland$234K
Ruben OlivaresCleveland$184K
Raymond RackleyCleveland$152K
Petar BajicCleveland$149K
Jorge Gutierrez AcevesCleveland$90K
Kenneth AngermeierCleveland$69K
Roger KhouriCleveland$57K
Xinyuan ZhangCleveland$51K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →